| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ADAR1 polymorphisms contribute to increased susceptibility in pediatric acute lymphoblastic leukemia
|
Cai, Mansi
|
|
|
102 |
9 |
p. 2483-2492
|
article
|
| 2 |
Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome
|
Tomulic Brusich, Katarina
|
|
|
102 |
9 |
p. 2633-2634
|
article
|
| 3 |
Age-related differences in risks and outcomes of 30-day readmission in adults with sickle cell disease
|
Chen, Ming
|
|
|
102 |
9 |
p. 2329-2342
|
article
|
| 4 |
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: prognostic indicators and the role of JAK2V617F measurable-residual disease monitoring by droplet-digital polymerase chain reaction
|
Li, Vivian W.K.
|
|
|
102 |
9 |
p. 2517-2527
|
article
|
| 5 |
Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients
|
Chistolini, A.
|
|
|
102 |
9 |
p. 2599-2605
|
article
|
| 6 |
Are accessory spleen screening and resection in refractory immune cytopenia an effective strategy or a waste of resources?
|
Rodríguez-Rodríguez, Sergio
|
|
|
102 |
9 |
p. 2309-2315
|
article
|
| 7 |
Characteristics and outcomes associated with venous thrombotic complications among patients with paroxysmal nocturnal hemoglobinuria
|
Grewal, Udhayvir S.
|
|
|
102 |
9 |
p. 2631-2632
|
article
|
| 8 |
Clinical features and prognosis of pediatric acute lymphocytic leukemia with JAK-STAT pathway genetic abnormalities: a case series
|
Hu, Mengze
|
|
|
102 |
9 |
p. 2445-2457
|
article
|
| 9 |
Clinical significance of plasma PD-L1+ exosomes in the management of diffuse large B cell lymphoma
|
Xu, Peng
|
|
|
102 |
9 |
p. 2435-2444
|
article
|
| 10 |
Comment on: JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response
|
Tsilimidos, Gerasimos
|
|
|
102 |
9 |
p. 2619-2620
|
article
|
| 11 |
Correction to: Efficacy and safety of ixazomib plus lenalidomide and dexamethasone following injectable pi‑based therapy in relapsed/refractory multiple myeloma
|
Abe, Yu
|
|
|
102 |
9 |
p. 2505
|
article
|
| 12 |
Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/rituximab (R2) based on real‑world data in patients with relapsed/refractory diffuse large B‑cell lymphoma
|
Nowakowski, Grzegorz S.
|
|
|
102 |
9 |
p. 2643-2644
|
article
|
| 13 |
COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma
|
Nachar, Victoria R.
|
|
|
102 |
9 |
p. 2635-2637
|
article
|
| 14 |
Cyclin D2-positive mantle cell lymphoma with t(2;12)(p12;p13) arising in immune deficiency/dysregulation
|
Kondo, Takumi
|
|
|
102 |
9 |
p. 2639-2640
|
article
|
| 15 |
Dynamic changes in circulating EBV-DNA load during treatment have prognostic values in EBV+ DLBCL-NOS: a Chinese cohort study
|
Xing, Tong-Yao
|
|
|
102 |
9 |
p. 2471-2481
|
article
|
| 16 |
Efficacy and Safety of Ixazomib Plus Lenalidomide and Dexamethasone Following Injectable PI-Based Therapy in Relapsed/Refractory Multiple Myeloma
|
Abe, Yu
|
|
|
102 |
9 |
p. 2493-2504
|
article
|
| 17 |
Erythema nodosum as a manifestation of cytokine release syndrome after CAR T-cell therapy
|
Duarte, Delfim
|
|
|
102 |
9 |
p. 2641-2642
|
article
|
| 18 |
Heyde syndrome
|
Suárez, Edwin Uriel
|
|
|
102 |
9 |
p. 2617-2618
|
article
|
| 19 |
Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary
|
Husi, Kata
|
|
|
102 |
9 |
p. 2555-2563
|
article
|
| 20 |
Insulin-like growth factor 1 receptor inhibits the proliferation of acute myeloid leukaemia cells via NK cell activation
|
Wang, ShuQing
|
|
|
102 |
9 |
p. 2353-2364
|
article
|
| 21 |
Mast cell leukemia associated with essential thrombocythemia: a type of MCL-AHN (MCL-AMN)
|
Zanelli, Magda
|
|
|
102 |
9 |
p. 2621-2623
|
article
|
| 22 |
Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia
|
Zhao, Jin
|
|
|
102 |
9 |
p. 2565-2587
|
article
|
| 23 |
Molecular insights into hereditary elliptocytosis and pyropoikilocytosis: NGS uncovers multiple potential candidate genes
|
Shome, Durjoy K.
|
|
|
102 |
9 |
p. 2343-2351
|
article
|
| 24 |
MYC-targeted genes predict distant recurrence in patients with ocular adnexal extranodal marginal zone lymphoma
|
Zhu, Tianyu
|
|
|
102 |
9 |
p. 2413-2423
|
article
|
| 25 |
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
|
Li, Jia-Ying
|
|
|
102 |
9 |
p. 2459-2469
|
article
|
| 26 |
Paroxysmal nocturnal hemoglobinuria with ulcerative colitis
|
Hayashino, Kenta
|
|
|
102 |
9 |
p. 2625-2626
|
article
|
| 27 |
Platelet is an unfavorable prognostic biomarker and associated with leukemia stem cells and immunomodulatory factors in acute myeloid leukemia
|
Zhang, Qing
|
|
|
102 |
9 |
p. 2365-2373
|
article
|
| 28 |
Positron emission tomography to detect bone marrow involvement for patients with follicular lymphoma: a systematic review and meta-analysis
|
Zheng, Yaxin
|
|
|
102 |
9 |
p. 2403-2412
|
article
|
| 29 |
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)
|
Pohlmann, Alexander
|
|
|
102 |
9 |
p. 2543-2553
|
article
|
| 30 |
Prognostic value of soluble programmed cell death ligand-1 (sPD-L1) in lymphoma: a systematic review and meta-analysis
|
Ding, Yangyang
|
|
|
102 |
9 |
p. 2425-2434
|
article
|
| 31 |
Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review
|
Tan, Kai-Wen
|
|
|
102 |
9 |
p. 2397-2402
|
article
|
| 32 |
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group
|
Saburi, Masuho
|
|
|
102 |
9 |
p. 2507-2516
|
article
|
| 33 |
Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis
|
Zhang, Qiaolei
|
|
|
102 |
9 |
p. 2301-2308
|
article
|
| 34 |
Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years
|
Niu, Dongdong
|
|
|
102 |
9 |
p. 2375-2386
|
article
|
| 35 |
The efficacy of first salvage therapy determines the outcomes of adult patients with type 1 primary refractory acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
|
Yu, Zhiyou
|
|
|
102 |
9 |
p. 2627-2630
|
article
|
| 36 |
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease
|
Stadler, Michael
|
|
|
102 |
9 |
p. 2529-2542
|
article
|
| 37 |
The mTORC1 pathway participate in hyper-function of B cells in immune thrombocytopenia
|
Xiang, Yujiao
|
|
|
102 |
9 |
p. 2317-2327
|
article
|
| 38 |
Tigecycline as salvage treatment of febrile neutropenia in patients with haematological malignancies—a retrospective single-centre analysis of 200 cases
|
Geßner, Daniel
|
|
|
102 |
9 |
p. 2607-2616
|
article
|
| 39 |
Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemia
|
Lin, Fan
|
|
|
102 |
9 |
p. 2589-2598
|
article
|
| 40 |
Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis
|
Liu, Chunxiao
|
|
|
102 |
9 |
p. 2387-2395
|
article
|
Journal description